most citedUse of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective

2 citations · 3 across the 3 of their papers we have counts for

collaborators

3 papers

stat.AP2024★ 2 cited

Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective

Jie Chen, Susan Gruber, Hana Lee +13

Real-world data (RWD) and real-world evidence (RWE) have been increasingly used in medical product development and regulatory decision-making, especially for rare diseases. After o…

stat.AP2024★ 1 cited

Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective

Jie Chen, Lei Nie, Shiowjen Lee +13

Developing drugs for rare diseases presents unique challenges from a statistical perspective. These challenges may include slowly progressive diseases with unmet medical needs, poo…

cs.CV2022

NTIRE 2022 Challenge on Efficient Super-Resolution: Methods and Results

Yawei Li, Kai Zhang, Radu Timofte +108

This paper reviews the NTIRE 2022 challenge on efficient single image super-resolution with focus on the proposed solutions and results. The task of the challenge was to super-reso…